Abstract:In the post-genomic era, systems biology is central to the biological sciences. Functional genomics such as transcriptomics and proteomics can simultaneous determine massive gene or protein expression changes following drug treatment or other intervention. However, these changes can't be coupled directly to changes in biological function. As a result, metabonomics and its many pseudonyms (metabolomics, metabolic profiling, etc.) have exploded onto the scientific scene in the past several years. Metabonomics is a rapidly growing research area and a system approach for comprehensive and quantitative analysis of the global metabolites in a biological matrix. Analytical chemistry approach is necessary for the development of comprehensive metabonomics investigations. Fundamentally, there are two types of metabonomics approaches: mass-spectrometry (MS) based and nuclear magnetic resonance (NMR) methodologies. Metabonomics measurements provide a wealth of data information and interpretation of these data relies mainly on chemometrics approaches to perform large-scale data analysis and data visualization, such as principal and independent component analysis, multidimensional scaling, a variety of clustering techniques, and discriminant function analysis, among many others. In this review, the recent development of analytical and statistical techniques used in metabonomics is summarized. Major applications of metabonomics relevant to clinical and preclinical study are then reviewed. The applications of metabonomics in study of liver diseases, cancers and other diseases have proved useful both as an experimental tool for pathogenesis mechanism re-search and ultimately a tool for diagnosis and monitoring treatment response of these diseases. Next, the applications of metabonomics in preclinical toxicology are discussed and the role that metabonomics might do in pharmaceutical research and development is explained with special reference to the aims and achievements of the Consortium for Metabonomic Toxicology (COMET), and the concept of pharmacometabonomics as a way of predicting an individual's response to treatment is highlighted. Finally, the role of metabonomics in elucidating the function of the unknown or novel enzyme is mentioned.

Applications of metabonomics in individualized therapy of cancer

Metabonomics and its application in oncobiology research

Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.

Application of metabolomics in clinical and laboratory gastrointestinal oncology

Recent development of metabonomics and its applications in clinical research]

The Applications of Metabolomics in the Molecular Diagnostics of Cancer

Progress and Challenge in Development of Biotherapeutics Targeting MET Receptor for Treatment of Advanced Cancer.

Metabolomics in the fields of oncology: a review of recent research

New Metabolomic Insights Into Cancer

The Application of Bio-Nanotechnology in Tumor Diagnosis and Treatment: A View

Metabolomics and cellular altered pathways in cancer biology: A review

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy

Metabolomics in cancer research and emerging applications in clinical oncology

Recent advances in nanomedicine for metabolism-targeted cancer therapy

Application of metabolomics in the diagnosis of breast cancer: a systematic review

Metabolomics, metabolic flux analysis and cancer pharmacology

Omics‐Enhanced Nanomedicine for Cancer Therapy

The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties

Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future-A review

Metabolomics: A Tool to Envisage Biomarkers in Clinical Interpretation of Cancer

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis